Article
TUNA patients show no more need for retreatment after 5 years
When drugs have failed, transurethral needle ablation (TUNA) has shown to be an effective long-term option for men suffering from BPH, according to recently published data.
Related Videos
Khurshid Ghani, MD, on trial of stent omission following ureteroscopy
Karyn S. Eilber, MD, shares her reaction to genitourinary syndrome of menopause guidelines
Expert discusses the relationship between RCTs and real-world efficacy of prostate cancer treatments
Treatment Decisions in Patients With Low- vs High-Volume Disease
Findings in the Docetaxel-Naive Patient Population
Endourologist discusses shared decision-making and laser lithotripsy
Shreyas Joshi, MD, recaps AUA session on chemotherapy vs novel NMIBC options
Joshua J. Meeks, MD, PhD, discusses NIAGARA data for patient undergoing cystectomy
Shay Rajavel, MS3, on CO2 gas embolism during single-port partial nephrectomy
Kevin Zorn, MD, on preserving ejaculation with BPH therapies
Related Content
